Skip to content

Author

Jiao-Jiao Wei

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Dual-targeted therapy with ustekinumab and vedolizumab as a novel rescue strategy: achieving high clinical response rates in Crohn's disease refractory to both monotherapies.

BACKGROUND Managing Crohn's disease is challenging as a substantial proportion of patients lose response to biologics. This study evaluated dual targeted therapy (DTT) with ustekinumab (UST) and vedolizumab (VDZ) in patients refractory to both agents as monotherapies. METHODS This retrospective study enrolled 23 pati...

Chong Lu, Tao Ling, Ya-Fang Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.